Xingli Zhao
Papers
1
Total Citations
6
H-Index
1
About
Dr. Xingli Zhao is a pioneering researcher at the intersection of nanomedicine, precision therapeutics, and vascular biology. Their most notable contribution is the development of an artificial biomarker-based feedback-regulated system for personalized thrombolysis, which addresses a critical challenge in stroke treatment: balancing clot dissolution with hemorrhagic risk. By revealing the relationship between thrombus heterogeneity and thrombolysis resistance, Dr. Zhao’s work introduces a dynamic, patient-specific approach that could replace the conventional body weight-based medication strategy, significantly improving recanalization rates while reducing post-thrombolysis hemorrhage. This landmark 2025 study has already garnered 6 citations, reflecting its rapid impact in the field. Dr. Zhao’s research integrates cutting-edge materials science with clinical needs, offering a transformative pathway toward safer, more effective treatments for thrombotic disorders. Their work stands out for its translational potential, bridging the gap between bench-side innovation and bedside precision medicine. For students and researchers, Dr. Zhao exemplifies how understanding biological heterogeneity can drive next-generation therapeutic design.
Research Focus
Key Achievements
Top Papers
- 1